One group of people that spends their life pursuing the goal of making the lives of all humanity better is medical researchers, doctors and everyone else that works in the field. With the increase in funding to look for cures to some of the main ailments that are affecting the society, companies and laboratories are coming up and starting their own initiatives on LinkedIn. One of these companies is Amphivena Therapeutics. The company specializes in looking for treatments and therapies that can deal with and if possible, eliminate all manner of hematologic malignancies.
JeanMarie Guenot has had a long and illustrious career in the world of science. She started out when she was a student of medicinal and physical chemistry at the University. After she had completed and attained her bachelor’s degree, she decided to go ahead and attain an MBA from the Wharton School of the University of Pennsylvania and a PhD from the University of California in San Francisco. She started off the career climb as a principal scientist at Hoffman-La-Roche. Here, she was the one coordinating the research that was going on about all manner of metabolic disorders and the treatments and therapies that could successfully treat them. Jeanmarie Guenot proceeded to Atlas Ventures where she was managing several venture capital investments and dealt with companies that are connected with life science. She has also been involved in the study and research into autoimmune diseases, inflammation and oncology.
Another company that she worked with in the past was SKS ocular. This is an institute that was carrying out research on disorders such as glaucoma and macular degeneration. There was a time Jeanmarie Guenot acted as an advisor for Hoffman-La Roche. When she was working as a licenser, manager and acquirer of commercial property at Bio Pharma, she helped the company get appropriate treatments for cancer through the mergers and acquisitions that she engineered.
JeanMarie Guenot goal in life has been to gather all the experience she needs to be successful in her field. Guenot is a role model and an inspiration to many people who wish to make a difference in life science.
Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies
Eric Lefkofsky announced that Tempus had entered into a partnership with the University of Chicago last month. Tempus will give doctors at the institution data so that they can treat cancer patients in a better way. The company will give breast cancer specialists the tools to perform molecular sequencing and analysis. This will help them to come up with a personalized treatment scheme for each patient. The company will perform analyses on the data from various patients to see if they can tell how the patients will respond to the treatment prescribed.
Dr. OlufunmilayoOlopade is a professor of Medicine at the University. He noted that there is minimal data on breast cancer patients even though it is one of the most prevalent forms of cancer. This forces physician to make uninformed decisions because they do not have specific genetic information.Olopade went on to state that he was excited about the partnership with Tempus. He was glad that the university could help them build the largest breast cancer molecular data set.
The University of Chicago is one of many organizations that has struck a partnership with Tempus. They have entered into partnerships with the University of Michigan, Penn Medicine, and the Robert Lurie Comprehensive Cancer Center of Northwestern University. Eric Lefkofsky is the CEO and co-founder of Tempus. He is the chairman and co-founder of Groupon, the highly successful e-commerce marketplace. He also started Mediaocean. This is a media procurement technology provider and Uptake Technologies. It is a predictive analytics company.Lefkofsky has been heavily involved in charity. This led him to establish the Lefkofsky Family Foundation in 2006. He started the charitable foundation with his wife. Its primary goal is to enhance communities worldwide. Lefkofsky is a graduate of the University of Michigan. He received a J.D from the same university. Lefkofsky also gives lectures and is an adjunct professor at the University of Chicago.
When it comes to great hair care products, cleansing conditioners are some of the very best to have ever been produced. There are many forms of cleansing treatment products, but these fantastic conditioners outperforms them all. Even the tried and true shampoo can’t duplicate the results to some degree. Did you know that many of the top brands for cleansing conditioners are loaded with toxins? That’s right! Though they may help the user achieve a specific look or result for short term success, these toxins tend to cause problems down the line in the form of hair breakage, dryness, itch, dullness, and even hairloss. The best thing for you to do is to tale a natural approach instead and that approach comes from WEN by Chaz.
WEN by Chaz Hair Care Products were developed by celebrity hair care stylist Chaz Dean. This guy has many years of experience under his belt and has worked with some of the most high profile individuals. The brand’s cleansing conditioners are simply amazing as they’ll produce some of the very best results. Here are a few of the conditioning products below:
5-in1 Cleansing Treatment
Pomegranate Extract Cleansing Conditioner
Sweet Almond Mint Cleansing Conditioner
Chamomile Extract Cleansing Conditioner
Tea Tree Cleansing Conditioner
Cucumber Cleansing Conditioner
And many more
This only scratches the surface of products, but just know that these formulas are safe to use on a consistent basis and will provide some of the very best results. Ease of use is also another bonus as these conditioners are easy to apply as well as easy to rinse out. WEN by Chaz delivers everytime, all of the time.
Find more on MerchantCircle.com
We all know that cancer is one of the world’s leading medical problems in the world. Cancer is an epidemic in the world. What makes the situation worse is the situation is the many types of cancer. From leukemia to cancer of the bones, experts have invested their time in researching with the aim to find a cure. As the research continues, experts discover more devastating issues about the disease. Cancer has several structures and it is vital for the medical practitioners to arrest the disease at an early stage. That is why Eric Lefkofsky is instrumental in the field of science. Eric has invested his time and resources in the great cause of finding a cure for cancer.
Eric Forms Tempus
Eric’s life revolves around entrepreneurship and investment. One thing he has taken his time in is the foundation of Tempus, where he is the Chief Executive Officer. Tempus is a health technology company. It enables medical practitioners to offer personalized treatment for cancer via an interactive and analytical platform. Tempus offers genomic sequence services through analyzing molecular and therapeutic information to empower medical practitioners to create time and data driven decisions for cancer treatment. The objective of Tempus is for every cancer patient to benefit from the treatment of the patients who were earlier treated. Through Tempus, Eric is involved in finding the technology for the cure of cancer. Tempus employs high standard of technology aimed at treating cancer while avoiding the core side effects of cancer treatment. Check forbes.com and read additional info.
In 2001, Eric Lefkofsky co founded a group called InnerWorkings to offer smaller firms with printing services in the procurement department. Through his entrepreneurial skills, InnerWorkings grew into a publically shared company in 2006. Eric merged with Keywell to form a logistics firm called Echo Global Logistics which attracted many investors leading to its growth and success. In 2007, Eric co founded Groupon, leading to its endorsement by several major investors. Groupon received millions in the form of investment. In 2010, Forbes named the company as the fastest growing in history. Later in that year, Eric Lefkofsky co founded Lightbank, a firm committed to assisting other businesses in Chicago to succeed.
To learn more about him, check his facebook.com page.
Social Media presence
Eris’s social media presence is dominated by cancer tweets and posts. He has approximately 6,000 followers on twitter and most of his posts focus on finding the cure for cancer and investment. He educates the society through his social media platforms. He also shares his daily life experience as a way of engaging the community.
More on https://www.tempus.com/about-us/